Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors
Youichi Kawakita(Takeda (Japan)), Tomoyasu Ishikawa(Takeda (Japan)), Tadashi Yusa(Takeda (Japan)), Satoshi Sogabe(Takeda (Japan)), Hidehisa Iwata(Takeda (Japan)), Toshiya Tamura(Takeda (Japan)), Hidenori Kamiguchi(Takeda (Japan)), Hiroshi Miki(Takeda (Japan)), Yoshikazu Ohta(University of Miyazaki), Toshimasa Tanaka(Takeda (Japan)), Masaki Seto(Takeda (Japan)), Tomohiro Ohashi(Takeda (Japan))
Cited by 79
Related Papers
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
|Journal of Biological Chemistry|2011|441
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
Structure-Based Approach for the Discovery of Pyrrolo[3,2-<i>d</i>]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors
|ACS Medicinal Chemistry Letters|2012|171
Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory Effect
|Journal of Medicinal Chemistry|1996|151
CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
|Nature Communications|2017|139